K. Baeg

Assessing the Prognostic Validity of the American Joint Committee on Cancer Staging Classification for Midgut Neuroendocrine Tumors.

J. Wisnivesky, M. Kim, J. Yang, 2021, Pancreas.

Association between somatostatin analogues and diabetes mellitus in gastroenteropancreatic neuroendocrine tumor patients: A Surveillance, Epidemiology, and End Results‐Medicare analysis of 5235 patients

A. Leiter, J. Wisnivesky, E. Gallagher, 2021, Cancer reports.

Predictors of Recurrence and Survival in Patients With Surgically Resected Pancreatic Neuroendocrine Tumors.

D. Metz, J. Wisnivesky, J. Starr, 2020, Pancreas.

Effect of treatment center volume on outcomes in gastroenteropancreatic neuroendocrine tumor patients

J. Wisnivesky, M. Kim, S. Rustgi, 2018, BMC Cancer.

Survival of Patients With Gastroenteropancreatic Neuroendocrine Tumors and Diabetes Mellitus

M. Kim, K. Baeg, S. Thapi, 2021, Pancreas.

Incidence Trends of Gastroenteropancreatic Neuroendocrine Tumors in the United States.

J. Wisnivesky, M. Kim, A. Aronson, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Effect of treatment center volume on outcomes in gastroenteropancreatic neuroendocrine tumor patients

J. Wisnivesky, M. Kim, S. Rustgi, 2021, BMC cancer.